FDA Inspection 1276292 - Paul Schulz, M.D. - July 22, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Paul Schulz, M.D., with an inspection on July 22, 2025, issued by the Dallas District Office, covering human drugs.

Company: Paul Schulz, M.D.
Inspection Date: July 22, 2025
Product Type: Human Drugs
Office: Dallas District Office

Open in Dashboard

ID · 701d1a8e-9863-4ed7-abae-fbbd380a3eaa

Violation Codes3

21 CFR 312.5021 CFR 312.6021 CFR 312.62(b)

Full citation text and observation details available on the Dashboard.